tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
CTXR is currently covered by 2 analysts with an average price target of $29.22. This is a potential upside of $27.4 (1505.49%) from yesterday's end of day stock price of $1.82.
Citius Pharmaceuticals's activity chart (see below) currently has 6 price targets and 20 ratings on display. The stock rating distribution of CTXR is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 15.87% with an average time for these price targets to be met of 503 days.
Highest price target for CTXR is $6, Lowest price target is $6, average price target is $6.
Most recent stock forecast was given by JASON KOLBERT from BENCHMARK on 12-Aug-2025. First documented stock forecast 22-May-2018.
Currently out of the existing stock ratings of CTXR, 8 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$6
$4.55 (313.79%)
$6
2 months 12 days ago
(12-Aug-2025)
1/7 (14.29%)
$4.72 (368.75%)
965
Buy
11 months 13 days ago
(11-Nov-2024)
1/3 (33.33%)
$75.09 (301.45%)
544
Buy
$4
$3.32 (488.24%)
3 years 10 months 24 days ago
(01-Dec-2021)
0/1 (0%)
$2.4 (150.00%)
What is CTXR (Citius Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on CTXR (Citius Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on CTXR (Citius Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on CTXR (Citius Pharmaceuticals)?
Which analyst is the currently most bullish on CTXR (Citius Pharmaceuticals)?
Which analyst is the currently most reserved on CTXR (Citius Pharmaceuticals)?
